Search results for "Cardiovascular events"
Little benefit, many harms from niacin, study finds
Taking niacin didn't significantly reduce vascular events and did cause a variety of serious side effects for high-risk patients, a new study found.
https://immattersacp.org/weekly/archives/2014/07/22/1.htm
22 Jul 2014
Blood pressure drugs likely to prevent stroke, death from mild hypertension
Pharmacologic treatment of blood pressure may prevent major cardiovascular events and death in patients with uncomplicated stage 1 hypertension, according to a systematic review.
https://immattersacp.org/weekly/archives/2014/12/23/2.htm
23 Dec 2014
Higher-potency statins associated with more new diabetes cases
Patients taking higher-potency statins for secondary prevention are more likely to develop diabetes than those on lower-potency statins, a new study found.
https://immattersacp.org/weekly/archives/2014/06/10/1.htm
10 Jun 2014
Preventive aspirin inflames opinions
Aspirin's long-standing role in cardiovascular health does not resolve its precise benefit in terms of cardiovascular prevention, specifically in patients who haven't had a myocardial infarction or stroke.
https://immattersacp.org/archives/2015/05/aspirin.htm
1 May 2015
Treatment of mild hypertension is not associated with improved outcomes
Treating patients with mild hypertension for primary prevention does not significantly reduce their morbidity or mortality, according to a new Cochrane review.
https://immattersacp.org/weekly/archives/2012/08/21/1.htm
21 Aug 2012
Rosuvastatin, atorvastatin compared on effectiveness, safety in industry-funded trial
Analysis of a randomized trial in South Korea found that patients randomized to rosuvastatin developed type 2 diabetes requiring medication at a rate of 7.2%, compared to 5.3% among those given atorvastatin.
https://immattersacp.org/weekly/archives/2023/10/24/4.htm
24 Oct 2023
FDA announces draft guidance for industry on reduction of sodium
The FDA draft guidance provides target short- and long-term mean and upper bound sodium concentrations for food categories and is particularly aimed at national and regional restaurant chains and food manufacturers whose products make up a significant proportion of national sales.
https://immattersacp.org/weekly/archives/2016/06/07/1.htm
7 Jun 2016
Adding ezetimibe to statins in ACS may improve cardiovascular outcomes
Reduction of LDL cholesterol levels may explain the effect of statins on coronary heart disease.
https://immattersacp.org/weekly/archives/2015/06/09/2.htm
9 Jun 2015
Calculating risk for cholesterol drugs
Differing guidelines and a new class of drugs may cause uncertainty on the part of patients and practitioners.
https://immattersacp.org/archives/2015/11/cholesterol.htm
1 Nov 2015
MKSAP Quiz: Evaluation of risk for cardiovascular disease
A 49-year-old man is evaluated during a routine examination. He is asymptomatic but is concerned about his risk for cardiovascular disease. Medical history is notable for hypertension. He is a nonsmoker, and he works as an executive at a highly successful company. Family history is noncontributory. His only medication is hydrochlorothiazide. Following a physical exam and cholesterol and glucose testing, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2016/02/09/3.htm
9 Feb 2016